Hi all, perhaps I can be of some help on putting t
Post# of 36537
(Total Views: 383)
Posted On: 09/28/2020 2:43:18 AM
Hi all, perhaps I can be of some help on putting this opportunity into perspective:
I’m not sure about what margins GNBT has for this, but we are in the industry (medical) and the market range for revenues as it applies to our CPT codes reimbursement in relationship to the device cost is a range between 15%-25% of the govt reimbursement being spent on our 1-device.
In regard to SAAS, we pay approximately 1.5% for annual license for the business software we use in relation to our revenues. Just sharing for perspective purposes. 25% I believe is a reasonable assumption on gross revenues, especially considering the potential for direct charging and the relatively low per transaction cost.
Excited for this week, Go GNBT!!
I’m not sure about what margins GNBT has for this, but we are in the industry (medical) and the market range for revenues as it applies to our CPT codes reimbursement in relationship to the device cost is a range between 15%-25% of the govt reimbursement being spent on our 1-device.
In regard to SAAS, we pay approximately 1.5% for annual license for the business software we use in relation to our revenues. Just sharing for perspective purposes. 25% I believe is a reasonable assumption on gross revenues, especially considering the potential for direct charging and the relatively low per transaction cost.
Excited for this week, Go GNBT!!
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼